Big Pharma's Doctor Control - Dr Jen Gunter and Doctor Mike
Lawsuits Claim Pfizer Failed to Warn of Brain Tumor Risk From Birth Control Shot
If Pfizer is successful, consumers may find it harder to hold drug makers accountable for inadequate warning labels.“…like Pfizer, #AstraZeneca is getting a three-year reprieve on having certain tariffs levied on its pharmaceutical imports. Trump noted that the reason manufacturers are agreeing to deals is because of his tariff threats.”
The next part is extra strange 👀*
“Both companies said the details of their arrangements were confidential.”
~~
1 of 2🧵
#USA #US #USpol #healthcare #health #DrugPrices #BigPharma #PharmaceuticalCompanies #Pfizer #tariffs #trump *#MyThoughts
—
https://www.cnn.com/2025/10/10/politics/lower-drug-prices-trump-announcement
Pharmaceutical corporation Eli Lilly and Company plans to build a $6.5 billion manufacturing hub near Lake Houston, the company announced Tuesday.
#Business #HealthScience #Houston #Local #MedicineWellness #News #EliLilly #GovGregAbbott #LakeHouston #PharmaceuticalCompanies #WeightLoss #WeightLossDrugs
The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing hub is slated to be built at Generation Park near Lake Houston and will produce a new weight-loss drug.
David Armstrong has been a health reporter for decades, so he thought he was prepared for the cost of being sick in America when he was diagnosed with cancer at the beginning of 2023. But even he was shocked to find that Revlimid, the drug that keeps his incurable multiple myeloma somewhat at bay, costs almost $1,000 for a daily pill. Here’s his story for @ProPublica about how it came to cost so much and why the price keeps being hiked. When Mark Alles, president of the drug’s manufacturer Celgene, appeared before the House Oversight Committee in 2020, he was quizzed by then-Rep. Katie Porter (D-Calif.). She concluded: “The drug didn’t get any better. The cancer patients didn’t get any better. You just got better at making money. You just refined your skills at price gouging.”
https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma
#Health #Pharma #PharmaceuticalCompanies #Medication #Drugs #Cancer #Newstodon #NewstodonFriday #FollowFriday